Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

GeoVax Labs, Inc. (GOVX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

GeoVax Labs is a biotechnology company focused on the development of vaccines to prevent and fight HIV/AIDS. GeoVax vaccines are designed to be used in uninfected people to prevent acquisition of HIV-1 and to limit the progression to AIDS if … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

PharmAthene, Inc. (PIP) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

PharmAthene develops and commercializes medical countermeasures against biological and chemical weapons. PIP’s lead product development programs include: SparVax™ – a second generation recombinant protective antigen (rPA) anthrax vaccine; Recombinant BChE- a novel bioscavenger for the prevention and treatment of morbidity … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Trimel Pharmaceuticals Corporation (TRL) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Trimel Pharmaceuticals specializes in the development of medications for female sexual health and conditions associated with aging and wellbeing. The company is currently developing multiple product opportunities, including CompleoTRT, which is a bio-adhesive intranasal testosterone gel presently in Phase III … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

U.S. Geothermal, Inc. (HTM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

U.S. Geothermal, a leader in renewable energy development, currently operates geothermal power projects at Raft River, Idaho, and San Emidio, Nev. The company’s third operating power project, the Neal Hot Springs project, is currently under construction. U.S. Geothermal holds geothermal … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

FriendFinder Networks, Inc. (FFN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

FriendFinder Networks is a leading Internet and technology company that provides services in the rapidly growing markets of social networking and Web-based video sharing. The company operates several of the most heavily trafficked Web sites in the world, including AdultFriendFinder.com, … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Resverlogix Corp. (RVX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is currently developing RVX-208, which is a first-in-class small molecule for treating atherosclerosis and the first BET bromodomain inhibitor in clinical trials. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Novavax, Inc. (NVAX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Novavax is a global clinical-stage biopharmaceutical company engaged in creating novel vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates with the goal of … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

ADVENTRX Pharmaceuticals, Inc. (ANX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for the treatment of various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications arising from sickle … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

BioSante Pharmaceuticals, Inc. (BPAX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

BioSante Pharmaceuticals is engaged in developing high-value, medically needed pharmaceutical products. The company’s products include LibiGel for treating female sexual dysfunction, which is in Phase III clinical development. The company is also developing a portfolio of cancer vaccines, with 17 … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Nanosphere, Inc. (NSPH) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Nanosphere is the developer, manufacturer and marketer of an advanced molecular diagnostics platform. The company’s platform, the Verigene System, is designed to detect life-threatening infections and cardiovascular diseases. The Verigene System is easy to use, cost-effective and facilitates simple, low-cost … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment